Study record · GHRP-6
Human pharmacokinetics of GHRP-6
Human exposure and pharmacokinetics were characterized across three IV dose levels.
Key result
Human exposure and pharmacokinetics were characterized across three IV dose levels.
Study details
Study designHealthy-volunteer pharmacokinetic study
PopulationHealthy men
Sample size9
RouteIntravenous
Regimen / exposure100, 200 or 400 micrograms/kg
DurationSingle-dose
ComparatorDose groups
Primary endpoint / questionPharmacokinetics and endocrine response
Safety resultSmall study; not a lifestyle-outcome trial.
Key limitationsDoes not establish performance, body-composition or recovery benefits.
Registry / identifierPMID 23099431